Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/23/2003CA2480763A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003CA2480759A1 Improved prodrugs of cc-1065 analogs
10/23/2003CA2480758A1 Tyrosine kinase inhibitors
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/23/2003CA2480512A1 Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480403A1 Drug-complex microparticles and methods of making/using same
10/23/2003CA2480365A1 Iron dextrin compounds for the treatment of iron deficiency anaemia
10/23/2003CA2480331A1 Lotion for therapy of dermatitis
10/23/2003CA2480221A1 Cream for therapy of dermatitis
10/23/2003CA2480213A1 Use of interleukin-19 to treat ovarian cancer
10/23/2003CA2480176A1 Use of interleukin-24 to treat ovarian cancer
10/23/2003CA2479714A1 Branched polyamine steroid derivatives
10/23/2003CA2479519A1 Use of interleukin-19 to treat cervical cancer
10/23/2003CA2478392A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
10/23/2003CA2477692A1 Cyanamides useful as reversible inhibitors of cysteine proteases
10/23/2003CA2470016A1 Antibiotic product, use and formulation thereof
10/23/2003CA2469736A1 Diphenhydramine tannate solid dose compositions and methods of use
10/23/2003CA2469338A1 Diphenhydramine tannate liquid and semi-solid compositions and methods of use
10/23/2003CA2466301A1 Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
10/23/2003CA2453256A1 Diphenhydramine tannate compositions and methods of use
10/23/2003CA2448525A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/23/2003CA2383243A1 Method for inhibiting fibrogenesis
10/22/2003EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen
10/22/2003EP1354961A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354888A1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1354878A2 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
10/22/2003EP1354873A1 Salt of perindopril and pharmaceutical compositions containing it
10/22/2003EP1354870A1 Dihydroceramide desaturase inhibitors.
10/22/2003EP1354868A1 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof
10/22/2003EP1354607A1 Solution for peritoneal dialysis and two-chambers bag therefor
10/22/2003EP1354604A1 Combinations for cardiovascular indications
10/22/2003EP1354603A1 Concomitant drugs
10/22/2003EP1354602A1 Medicinal compositions containing diuretic and insulin resistance-improving agent
10/22/2003EP1354601A1 Transplantation rejection inhibitors
10/22/2003EP1354595A1 Composition containing extracts of butyrospermum parkii and its use as medicament or dietary supplement
10/22/2003EP1354594A1 Combinations of an extract of a vaccinium type plant and a carotene
10/22/2003EP1354590A1 Drugs against articular failure
10/22/2003EP1354589A1 Angiogenesis inhibitors
10/22/2003EP1354588A1 Method for delivering benzindene prostaglandind by inhalation
10/22/2003EP1354587A1 Medicinal compositions for oral use
10/22/2003EP1354586A1 The use of hydroxpyridone-derivatives in wound healing
10/22/2003EP1354585A1 Use of molindone or derivatives thereof for the manufacture of a medicament in the treatment of oppositional defiant disorders and conduct disorders
10/22/2003EP1354584A1 Preventives for arthritis
10/22/2003EP1354583A2 Aerosols containing beclomethasone nanoparticle dispersions
10/22/2003EP1354582A2 Emulsion preconcentrates containing cyclosporin or a macrolide
10/22/2003EP1354581A1 Porous substance and process for producing the same
10/22/2003EP1354580A1 Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same
10/22/2003EP1354518A1 Kernel oil from plant kernel, process for extracting same, pharmaceutical composition and use thereof
10/22/2003EP1354516A1 Multi-purpose acid compositions
10/22/2003EP1354199A2 Diagnosis and treatment of multiple sclerosis
10/22/2003EP1354196A2 Diagnostics, drug screening and treatment for cancer
10/22/2003EP1354055A1 Neocentromere-based mini-chromosomes or artificial chromosomes
10/22/2003EP1354046A2 A member of the lysyl oxidase gene family
10/22/2003EP1354032A2 Gene regulation therapy involving ferritin
10/22/2003EP1353968A1 Linear block polymer
10/22/2003EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
10/22/2003EP1353938A1 Androgenic 7-substituted 11-halogenated steroids
10/22/2003EP1353933A1 Method for purification of lactose
10/22/2003EP1353932A1 Compositions containing a ruthenium(iii) complex and a heterocycle
10/22/2003EP1353929A2 Streptogramin derivatives preparation thereof and compositions containing same
10/22/2003EP1353928A2 Process for preparing clopidogrel
10/22/2003EP1353927A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
10/22/2003EP1353926A1 Mikanolide derivatives, their preparation and therapeutic uses
10/22/2003EP1353924A1 Synthesis of temozolomide and analogs
10/22/2003EP1353922A1 Cyclin dependent kinase inhibiting purine derivatives
10/22/2003EP1353921A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
10/22/2003EP1353919A2 Novel quinuclidine derivatives and medicinal compositions containing the same
10/22/2003EP1353918A1 Morpholine derivatives as antagonists of orexin receptors
10/22/2003EP1353917A2 Novel process for the synthesis of 5-(4-fluorophenyl)-1-(2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl)-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353915A2 Therapeutic chroman compounds
10/22/2003EP1353914A2 Therapeutic chromone compounds
10/22/2003EP1353913A2 Therapeutic heterocyclic compounds
10/22/2003EP1353912A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
10/22/2003EP1353911A1 Antiviral agents
10/22/2003EP1353910A2 Lactam compound
10/22/2003EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
10/22/2003EP1353907A2 Phosphodiesterase 4 inhibitors
10/22/2003EP1353906A1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
10/22/2003EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase
10/22/2003EP1353904A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/22/2003EP1353903A2 Thiol-based naaladase inhibitors
10/22/2003EP1353902A2 Inhibitors of serine protease activity of matriptase or mtsp1
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353896A2 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
10/22/2003EP1353727A2 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drugor a statin, for the treatment of sexual dysfunction
10/22/2003EP1353700A1 Compositions of estrogen-cyclodextrin complexes
10/22/2003EP1353699A1 Cyclodextrin-drospirenone inclusion complexes
10/22/2003EP1353697A1 Method of preparing biological materials and preparation produced using same
10/22/2003EP1353696A2 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
10/22/2003EP1353695A2 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
10/22/2003EP1353694A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
10/22/2003EP1353693A2 Pharmaceutical combination containing a 4-quinazolineamine and another anti-neoplastic agent for the treatment of cancer
10/22/2003EP1353692A2 Methods and compositions for treatment of ocular neovascularization and neural injury
10/22/2003EP1353687A2 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof
1 ... 5302 5303 5304 5305 5306 5307 5308 5309 5310 5311 5312 5313 5314 5315 5316 5317 5318 5319 5320 5321 5322 ... 7860